DAL vs PACB · P/E 12, rev $61.64B vs rev $38.4M
Delta Air Lines Inc (DAL) versus Pacific Biosciences of California (PACB) — a side-by-side from cached financials, not a winner call.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Latest reported PACB revenue for 2025-09-30 was $38.4M. Net income was -$38.0M. Revenue was down 3.3% from 2025-06-30 to 2025-09-30. PACB currently screens at market cap $387.1M.
DAL currently screens at market cap $52.18B and trailing P/E 11.6. PACB currently screens at market cap $387.1M.
Not investment advice. Open the DAL and PACB stock pages for the full models.
Not investment advice.